These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3464432)

  • 1. Analysis of nuclear m-AMSA content by DNA fluorochrome competition.
    Andersson BS; Beran M; Barlogie B; Van NT; McCredie KB
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):883-9. PubMed ID: 3464432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative sequestration of m-AMSA in L1210 cells.
    Zwelling LA; Kerrigan D; Michaels S; Kohn KW
    Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
    Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
    Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
    Skinner WL; Murray D; Kohli V; Beran M; McCredie KB; Freireich EJ; Andersson BS
    Br J Cancer; 1990 Jan; 61(1):51-5. PubMed ID: 2297490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR
    Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA; Estey E; Silberman L; Doyle S; Hittelman W
    Cancer Res; 1987 Jan; 47(1):251-7. PubMed ID: 3024817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic action and cell cycle effects of ALGA, a peptidic derivative of the antileukemic drug amsacrine.
    Collyn-d'Hooghe M; Bernier JL; Henichart JP
    Cancer Biochem Biophys; 1987 Sep; 9(3):257-64. PubMed ID: 3435897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.
    Hudecz F; Kajtár J; Szekerke M
    Nucleic Acids Res; 1981 Dec; 9(24):6959-73. PubMed ID: 6174949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC; Ashorn CL; Chan D; Zwelling LA
    Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
    Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
    Zwelling LA; Silberman L; Estey E
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids.
    Pommier Y; Mattern MR; Schwartz RE; Zwelling LA
    Biochemistry; 1984 Jun; 23(13):2922-7. PubMed ID: 6547848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.
    Andersson BS; Beran M; Stuckey SE; McCredie KB; Mavligit GM
    Med Oncol Tumor Pharmacother; 1987; 4(1):17-21. PubMed ID: 3600053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
    Pommier Y; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
    Andersson BS; Beran M; Bakic M; Silberman LE; Newman RA; Zwelling LA
    Cancer Res; 1987 Feb; 47(4):1040-4. PubMed ID: 3026621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.